TRD
Articles tagged with “TRD”
Glutamate Pathway Treatments Reshape TRD Care in 2026
New research highlights glutamate-targeting treatments for TRD, including esketamine and ketamine troches. Here's what it means for your care plan.
Esketamine vs. Troches: What TRD Patients Should Know
A new clinical review on esketamine for TRD highlights access barriers and patient preferences — here's what it means for ketamine troche therapy.
Esketamine TRD Access Gaps Open Doors for Troches
New clinician data on esketamine for TRD reveals access barriers that make compounded ketamine troches a practical frontline option for many patients.
Glutamate Pathways Are Reshaping TRD Treatment
A 2026 review highlights how glutamate-targeting drugs like esketamine and ketamine troches are redefining treatment-resistant depression care.
Ketamine Troches for Depression: Evidence and Protocols
Ketamine troches show significant promise for treatment-resistant depression. Review the clinical evidence, mechanisms of action, treatment protocols, and what to expect from troche-based antidepressant therapy.
Using Ketamine Troches for Maintenance vs. Acute Treatment
How maintenance dosing with ketamine troches works after initial response: weekly vs biweekly schedules, dose tapering, tolerance signs, avoiding burnout.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.